HomeUBX • NASDAQ
add
Unity Biotechnology Inc
Previous close
$0.98
Day range
$0.97 - $1.00
Year range
$0.85 - $3.10
Market cap
16.94M USD
Avg Volume
190.18K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.12M | 6.21% |
Net income | -7.30M | -26.11% |
Net profit margin | — | — |
Earnings per share | -0.43 | -26.47% |
EBITDA | -6.71M | 8.94% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 16.93M | -53.39% |
Total assets | 30.35M | -48.44% |
Total liabilities | 30.55M | -12.40% |
Total equity | -205.00K | — |
Shares outstanding | 17.21M | — |
Price to book | -97.70 | — |
Return on assets | -50.66% | — |
Return on capital | -65.71% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -7.30M | -26.11% |
Cash from operations | -6.36M | -22.65% |
Cash from investing | 6.78M | 194.24% |
Cash from financing | — | — |
Net change in cash | 419.00K | 103.39% |
Free cash flow | -3.48M | -64.88% |
About
Unity Biotechnology, Inc. is a publicly traded American biotechnology company that develops drugs that target senescent cells. Wikipedia
Founded
2011
Headquarters
Website
Employees
16
